We’ve just launched a new portal to help you explore stocks, crypto, ETFs, and more data

PODD

310.67001 USD
53.67
20.88%
Last update May 9, 3:59 PM EDT
Post-market
Day range
293.029999
312.16000
Previous close
257
Open
293.029999
Access this stock data via API
Subscribe
Insulet Corporation
310.67
53.67
20.88%

Overview

Description

Insulet Corporation is a prominent healthcare company specializing in medical devices, with a key focus on diabetes management. Its flagship product, the Omnipod Insulin Management System, is an innovative, tubeless insulin pump that offers users freedom and flexibility, addressing the lifelong needs of individuals with diabetes. The system is acclaimed for its discreet, water-resistant pods, which deliver continuous insulin delivery without the constraints of traditional insulin pumps. Insulet Corporation plays a crucial role in the medical technology industry by enhancing patient experiences and outcomes. Headquartered in Acton, Massachusetts, Insulet Corporation continues to pioneer advancements in insulin delivery solutions, directly impacting healthcare providers and improving the quality of life for diabetes patients globally. Its market significance is underscored by its commitment to innovation and accessibility, bridging the gap between technology and patient-centric care in the rapidly evolving healthcare sector.

About

CEO
Ms. Ashley A. McEvoy
Employees
3900
Address
100 Nagog Park
Acton, 01720, MA
United States
Phone
978 600 7000
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Medical Devices
Country
United States
MIC code
XNGS
Post-market

Exchange is currently open for post-market.
Post market session closes in 2 hours 12 minutes

17:48
00:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).